Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-11-26
DOI
10.3389/fphar.2020.592169
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Outbreak of a novel coronavirus
- (2020) Andrea Du Toit NATURE REVIEWS MICROBIOLOGY
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
- (2020) Yajing Fu et al. VIROLOGICA SINICA
- Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More
- (2020) Abinit Saha et al. ARCHIVES OF MEDICAL RESEARCH
- Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
- (2020) Abinit Saha et al. ARCHIVES OF MEDICAL RESEARCH
- Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak
- (2020) Chiranjib Chakraborty et al. ARCHIVES OF MEDICAL RESEARCH
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients
- (2020) Xiaohua Chen et al. CLINICAL INFECTIOUS DISEASES
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Consider TLR5 for new therapeutic development against COVID‐19
- (2020) Chiranjib Chakraborty et al. JOURNAL OF MEDICAL VIROLOGY
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- (2020) Mandeep R Mehra et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
- (2020) Mario Adán Moreno-Eutimio et al. MICROBES AND INFECTION
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
- (2020) Yang Song et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19
- (2020) Swapan K. Chatterjee et al. Frontiers in Molecular Biosciences
- SARS‐CoV ‐2 multifaceted interaction with the human host. Part II : Innate immunity response, immunopathology, and epigenetics
- (2020) Tasnim H. Beacon et al. IUBMB LIFE
- The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
- (2020) Tapan Behl et al. LIFE SCIENCES
- Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study
- (2020) Jing Chen et al. Expert Review of Respiratory Medicine
- Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases
- (2020) Zixin Shu et al. Frontiers of Medicine
- Severe COVID-19: what have we learned with the immunopathogenesis?
- (2020) Bruno Bordallo et al. Advances in Rheumatology
- Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV
- (2019) Yuting Jiang et al. Viruses-Basel
- Human Coronavirus: Host-Pathogen Interaction
- (2019) To Sing Fung et al. Annual Review of Microbiology
- Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein
- (2018) Jian Lei et al. ANTIVIRAL RESEARCH
- Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
- (2018) Wenfei Song et al. PLoS Pathogens
- Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy-Related Toxicities
- (2018) Bhagirathbhai R. Dholaria et al. BIODRUGS
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Control of adaptive immunity by the innate immune system
- (2015) Akiko Iwasaki et al. NATURE IMMUNOLOGY
- Analysis of Influence of Baicalin Joint Resveratrol Retention Enema on the TNF-α, SIgA, IL-2, IFN-γ of Rats with Respiratory Syncytial Virus Infection
- (2014) Kebin Cheng et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Natural products: A continuing source of novel drug leads
- (2013) Gordon M. Cragg et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Interspecies transmission and emergence of novel viruses: lessons from bats and birds
- (2013) Jasper Fuk-Woo Chan et al. TRENDS IN MICROBIOLOGY
- Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
- (2012) Thi Thanh Hanh Nguyen et al. BIOTECHNOLOGY LETTERS
- Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
- (2012) Yiwu Yan et al. CELL RESEARCH
- Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response
- (2012) Yan Li et al. MICROBES AND INFECTION
- Inhibitory activities of baicalin against renin and angiotensin-converting enzyme
- (2011) Y. F. Deng et al. PHARMACEUTICAL BIOLOGY
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Signaling by ROS drives inflammasome activation
- (2010) Fabio Martinon EUROPEAN JOURNAL OF IMMUNOLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Toll-like receptors and innate immunity
- (2009) Himanshu Kumar et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
- (2009) I. Glowacka et al. JOURNAL OF VIROLOGY
- Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2
- (2008) Shunxin Wang et al. VIRUS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started